Literature DB >> 9181264

Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients.

E Astorri1, P Fiorina, G A Contini, D Albertini, G Magnati, A Astorri, M Lanfredini.   

Abstract

BACKGROUND: Diabetes mellitus can induce a pattern of myocardial pathology known as specific diabetic cardiomyopathy, even if this is not clearly specified. HYPOTHESIS: The aim of our study was to evaluate the presence of preclinical myocardial damage in insulin- and non-insulin-dependent diabetic patients and controls by assessment with Doppler echocardiography.
METHODS: Twenty insulin-dependent diabetic (IDDM) patients, 10 non-insulin-dependent diabetic (NIDDM) patients, and 12 healthy individuals (C) as controls, matched for age, gender, and without overt cardiovascular disease, were assessed in this study.
RESULTS: Systolic function parameters presented normal values in the three groups, with the exception of a slight reduction in ventricular volume indices in the NIDDM group. Diastolic function was clearly impaired in both groups of patients versus that in healthy controls. In particular, ventricular filling was impaired in the NIDDM compared with the IDDM patients, especially the peak early filling rate E (p < 0.001). Moreover, in the IDDM group, the duration of diabetes (p < 0.01) and glycosilated hemoglobin value (HbA1C, p < 0.02) were higher than in the NIDDM group. Multiple regression analysis showed a significant inverse correlation between HbA1C and peak late filling rate A (R2 = 0.28) in both groups of patients and a direct correlation between velocity time integral E and age, duration of diabetes, and HbA1C (R2 = 0.46). The two groups presented a small, homogeneous number of cases with initial microangiopathy and borderline autonomic neuropathy, associated with microalbuminuria. Doppler echocardiography showed an early impairment of left ventricular filling, as well as an early preclinical alteration of myocardial function in diabetic patients, especially in the NIDDM group.
CONCLUSION: These early signs of cardiomyopathy could constitute a predisposing condition toward the high cardiac morbidity and mortality rate in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9181264      PMCID: PMC6656054          DOI: 10.1002/clc.4960200606

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  25 in total

1.  Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography.

Authors:  N B Schiller
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

Review 2.  Evidence for a specific heart disease of diabetes in humans.

Authors:  B M Fisher; B M Frier
Journal:  Diabet Med       Date:  1990-07       Impact factor: 4.359

3.  Does a clinically definable diabetic cardiomyopathy exist?

Authors:  M R Starling
Journal:  J Am Coll Cardiol       Date:  1990-06       Impact factor: 24.094

4.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study).

Authors:  M Galderisi; K M Anderson; P W Wilson; D Levy
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

5.  Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography.

Authors:  S W Zarich; B E Arbuckle; L R Cohen; M Roberts; R W Nesto
Journal:  J Am Coll Cardiol       Date:  1988-07       Impact factor: 24.094

6.  Myocardial mechanics in young adult patients with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise.

Authors:  K M Borow; J B Jaspan; K A Williams; A Neumann; P Wolinski-Walley; R M Lang
Journal:  J Am Coll Cardiol       Date:  1990-06       Impact factor: 24.094

Review 7.  The diabetic heart: clinical, experimental and pathological features.

Authors:  K H van Hoeven; S M Factor
Journal:  Acta Cardiol       Date:  1991       Impact factor: 1.718

8.  Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease.

Authors:  M Uusitupa; J Mustonen; M Laakso; P Vainio; E Länsimies; S Talwar; K Pyörälä
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

9.  Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus.

Authors:  T W Riggs; D Transue
Journal:  Am J Cardiol       Date:  1990-04-01       Impact factor: 2.778

10.  Basis for myocardial mechanical defects associated with non-insulin-dependent diabetes.

Authors:  S W Schaffer; M S Mozaffari; M Artman; G L Wilson
Journal:  Am J Physiol       Date:  1989-01
View more
  16 in total

Review 1.  Diastolic dysfunction: a link between hypertension and heart failure.

Authors:  Sophie Lalande; Bruce D Johnson
Journal:  Drugs Today (Barc)       Date:  2008-07       Impact factor: 2.245

Review 2.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 3.  Treatment of heart failure in patients with diabetes mellitus.

Authors:  Steven J Lavine; Steven D Gellman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Changes in Titin and Collagen Modulate Effects of Aerobic and Resistance Exercise on Diabetic Cardiac Function.

Authors:  Shunchang Li; Min Liang; Derun Gao; Quansheng Su; Ismail Laher
Journal:  J Cardiovasc Transl Res       Date:  2019-02-28       Impact factor: 4.132

Review 5.  A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy.

Authors:  Xinli Zhang; Chen Chen
Journal:  Endocrine       Date:  2012-02-10       Impact factor: 3.633

6.  Changes in diastolic dysfunction in diabetes mellitus over time.

Authors:  Aaron M From; Christopher G Scott; Horng H Chen
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

Review 7.  Advanced glycation end products: role in pathology of diabetic cardiomyopathy.

Authors:  Vijaya Lakshmi Bodiga; Sasidhar Reddy Eda; Sreedhar Bodiga
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 8.  [Diabetic cardiomyopathy--a type of coronary artery disease?].

Authors:  B Stratmann; I Stork; D Tschoepe
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

Review 9.  The diabetic myocardium.

Authors:  Thomas H Marwick
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

Review 10.  Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.

Authors:  Mandip Joshi; Sainath R Kotha; Smitha Malireddy; Vaithinathan Selvaraju; Abhay R Satoskar; Alexender Palesty; David W McFadden; Narasimham L Parinandi; Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2013-12-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.